1. Home
  2. GDC vs SCYX Comparison

GDC vs SCYX Comparison

Compare GDC & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDC
  • SCYX
  • Stock Information
  • Founded
  • GDC 2015
  • SCYX 1999
  • Country
  • GDC United States
  • SCYX United States
  • Employees
  • GDC N/A
  • SCYX N/A
  • Industry
  • GDC Steel/Iron Ore
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GDC Industrials
  • SCYX Health Care
  • Exchange
  • GDC Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • GDC 29.0M
  • SCYX 28.5M
  • IPO Year
  • GDC N/A
  • SCYX 2014
  • Fundamental
  • Price
  • GDC $3.21
  • SCYX $0.70
  • Analyst Decision
  • GDC
  • SCYX
  • Analyst Count
  • GDC 0
  • SCYX 0
  • Target Price
  • GDC N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • GDC 92.6K
  • SCYX 182.9K
  • Earning Date
  • GDC 08-13-2025
  • SCYX 08-07-2025
  • Dividend Yield
  • GDC N/A
  • SCYX N/A
  • EPS Growth
  • GDC N/A
  • SCYX N/A
  • EPS
  • GDC N/A
  • SCYX N/A
  • Revenue
  • GDC N/A
  • SCYX $2,630,000.00
  • Revenue This Year
  • GDC N/A
  • SCYX $410.22
  • Revenue Next Year
  • GDC N/A
  • SCYX $248.83
  • P/E Ratio
  • GDC N/A
  • SCYX N/A
  • Revenue Growth
  • GDC N/A
  • SCYX N/A
  • 52 Week Low
  • GDC $1.03
  • SCYX $0.66
  • 52 Week High
  • GDC $12.18
  • SCYX $2.21
  • Technical
  • Relative Strength Index (RSI)
  • GDC 49.15
  • SCYX 43.16
  • Support Level
  • GDC $3.13
  • SCYX $0.67
  • Resistance Level
  • GDC $3.69
  • SCYX $0.74
  • Average True Range (ATR)
  • GDC 0.40
  • SCYX 0.04
  • MACD
  • GDC -0.07
  • SCYX 0.00
  • Stochastic Oscillator
  • GDC 17.24
  • SCYX 18.79

About GDC GD Culture Group Limited

GD Culture Group Ltd focuses its business on two segments mainly through the Company and two subsidiaries. 1) AI-driven digital human creation and customization; 2) Live streaming and e-commerce. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: